| Synonyms: | |
| Status: | Approved (1989) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | P01BC02 |
| UNII: | TML814419R |
| InChI Key | XEEQGYMUWCZPDN-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H16F6N2O |
| Molecular Weight | 378.32 |
| AlogP | 4.45 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 45.15 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 26.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
CMGC protein kinase group
CMGC protein kinase CDK family
|
- | 12000 | - | - | - | |
|
Ion channel
Ligand-gated ion channel
Glycine receptor
|
2500 | - | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 2600-5623 | - | - | 95 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 113 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Malaria | 4 | D008288 | ClinicalTrials |
| Schistosomiasis haematobia | 3 | D012553 | ClinicalTrials |
| Malaria, Falciparum | 3 | D016778 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Pneumonia, Viral | 2 | D011024 | ClinicalTrials |
| Respiratory Insufficiency | 2 | D012131 | ClinicalTrials |
| Gliosarcoma | 1 | D018316 | ClinicalTrials |
| Leukoencephalopathy, Progressive Multifocal | 1 | D007968 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 53230-10-7 |
| ChEBI | 63681 |
| ChEMBL | CHEMBL416956 |
| DrugBank | DB00358 |
| FDA SRS | TML814419R |
| Human Metabolome Database | HMDB0014502 |
| Guide to Pharmacology | 4252 |
| KEGG | C07633 |
| PharmGKB | PA450348 |
| PubChem | 40692 |
| SureChEMBL | SCHEMBL21782 |